Tobevibart monotherapy and combination therapy with elebsiran achieved high virologic response and alt normalization in people living with the hepatitis delta virus after 12 and 24 weeks of treatment

San francisco--(business wire)---- $vir #hepatitisd--new data from vir biotechnology reinforces the potential for a transformative treatment for hepatitis delta, the most severe form of viral hepatitis.
ALT Ratings Summary
ALT Quant Ranking